Three Peaks Capital Management LLC decreased its stake in shares of Teleflex Incorporated (NYSE:TFX) by 16.0% during the first quarter, HoldingsChannel reports. The firm owned 42,309 shares of the medical technology company’s stock after selling 8,034 shares during the period. Teleflex accounts for 1.8% of Three Peaks Capital Management LLC’s portfolio, making the stock its 9th largest position. Three Peaks Capital Management LLC’s holdings in Teleflex were worth $10,788,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. Schwab Charles Investment Management Inc. raised its holdings in shares of Teleflex by 2.8% in the 4th quarter. Schwab Charles Investment Management Inc. now owns 180,172 shares of the medical technology company’s stock valued at $44,831,000 after acquiring an additional 4,903 shares in the last quarter. Quantitative Systematic Strategies LLC purchased a new stake in shares of Teleflex in the 4th quarter valued at about $228,000. Victory Capital Management Inc. raised its holdings in shares of Teleflex by 12.6% in the 4th quarter. Victory Capital Management Inc. now owns 9,555 shares of the medical technology company’s stock valued at $2,377,000 after acquiring an additional 1,067 shares in the last quarter. Comerica Bank raised its holdings in shares of Teleflex by 0.6% in the 4th quarter. Comerica Bank now owns 35,546 shares of the medical technology company’s stock valued at $9,778,000 after acquiring an additional 198 shares in the last quarter. Finally, US Bancorp DE raised its holdings in shares of Teleflex by 8.4% in the 4th quarter. US Bancorp DE now owns 16,901 shares of the medical technology company’s stock valued at $4,205,000 after acquiring an additional 1,311 shares in the last quarter. 89.96% of the stock is currently owned by institutional investors and hedge funds.

Shares of NYSE TFX opened at $278.81 on Thursday. The stock has a market cap of $12.62 billion, a P/E ratio of 33.19, a PEG ratio of 1.94 and a beta of 1.19. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.45 and a current ratio of 2.18. Teleflex Incorporated has a 1-year low of $195.36 and a 1-year high of $288.78.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, May 3rd. The medical technology company reported $2.15 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.94 by $0.21. The company had revenue of $587.23 million for the quarter, compared to analysts’ expectations of $568.29 million. Teleflex had a return on equity of 16.60% and a net margin of 7.51%. Teleflex’s revenue for the quarter was up 20.4% compared to the same quarter last year. During the same period last year, the firm posted $1.80 EPS. equities analysts expect that Teleflex Incorporated will post 9.83 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 15th. Investors of record on Tuesday, May 15th will be issued a dividend of $0.34 per share. The ex-dividend date of this dividend is Monday, May 14th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.49%. Teleflex’s dividend payout ratio is 16.19%.

In related news, Director George Babich, Jr. sold 2,500 shares of the firm’s stock in a transaction that occurred on Monday, March 26th. The stock was sold at an average price of $254.53, for a total transaction of $636,325.00. Following the transaction, the director now directly owns 8,794 shares in the company, valued at approximately $2,238,336.82. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Benson Smith sold 9,331 shares of the firm’s stock in a transaction that occurred on Monday, April 16th. The stock was sold at an average price of $260.52, for a total value of $2,430,912.12. Following the transaction, the director now owns 77,498 shares in the company, valued at $20,189,778.96. The disclosure for this sale can be found here. Over the last three months, insiders have sold 49,324 shares of company stock worth $12,935,358. 2.56% of the stock is currently owned by insiders.

TFX has been the topic of several recent analyst reports. Leerink Swann lowered their price target on Teleflex from $321.00 to $300.00 and set an “outperform” rating on the stock in a report on Friday, February 23rd. ValuEngine cut Teleflex from a “buy” rating to a “hold” rating in a report on Wednesday, March 7th. TheStreet cut Teleflex from an “a-” rating to a “c+” rating in a report on Monday, March 12th. Goldman Sachs Group initiated coverage on Teleflex in a report on Wednesday, April 4th. They issued a “neutral” rating and a $257.00 price target on the stock. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $293.00 price target (up previously from $285.00) on shares of Teleflex in a report on Thursday, May 3rd. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and six have given a buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $282.50.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site; and devices for treating coronary and peripheral vascular disease.

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.